Savant Capital LLC grew its position in shares of The Allstate Corporation (NYSE:ALL – Free Report) by 24.2% in the 2nd quarter, HoldingsChannel.com reports. The fund owned 35,829 shares of the insurance provider’s stock after buying an additional 6,978 shares during the quarter. Savant Capital LLC’s holdings in Allstate were worth $7,213,000 at the end of the most recent quarter.
Several other large investors also recently modified their holdings of the business. Arlington Trust Co LLC raised its position in Allstate by 261.8% during the 2nd quarter. Arlington Trust Co LLC now owns 123 shares of the insurance provider’s stock valued at $25,000 after purchasing an additional 89 shares during the last quarter. Hughes Financial Services LLC purchased a new position in shares of Allstate during the first quarter valued at approximately $28,000. Caitong International Asset Management Co. Ltd raised its holdings in shares of Allstate by 315.0% during the second quarter. Caitong International Asset Management Co. Ltd now owns 166 shares of the insurance provider’s stock valued at $33,000 after acquiring an additional 126 shares in the last quarter. Hilltop National Bank purchased a new stake in Allstate in the second quarter worth $34,000. Finally, Chilton Capital Management LLC bought a new stake in Allstate in the second quarter valued at $38,000. 76.47% of the stock is owned by institutional investors.
Allstate Price Performance
Shares of NYSE ALL opened at $202.29 on Friday. The company has a 50 day simple moving average of $201.86 and a two-hundred day simple moving average of $201.14. The Allstate Corporation has a fifty-two week low of $176.00 and a fifty-two week high of $215.70. The company has a market capitalization of $53.30 billion, a price-to-earnings ratio of 9.51, a P/E/G ratio of 0.69 and a beta of 0.35. The company has a debt-to-equity ratio of 0.37, a quick ratio of 0.43 and a current ratio of 0.43.
Analyst Ratings Changes
ALL has been the subject of several research reports. Roth Capital set a $230.00 price objective on shares of Allstate and gave the stock a “buy” rating in a report on Friday, September 26th. Wells Fargo & Company increased their price target on shares of Allstate from $202.00 to $216.00 and gave the stock an “equal weight” rating in a research note on Friday. Cantor Fitzgerald upgraded shares of Allstate to a “hold” rating in a report on Wednesday, August 13th. Barclays reaffirmed an “underweight” rating and set a $198.00 price objective (up from $188.00) on shares of Allstate in a research report on Thursday, July 31st. Finally, Raymond James Financial reissued a “strong-buy” rating and issued a $260.00 target price (up previously from $250.00) on shares of Allstate in a research report on Monday, August 4th. Two research analysts have rated the stock with a Strong Buy rating, twelve have given a Buy rating, four have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $236.53.
Check Out Our Latest Report on ALL
Allstate Company Profile
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
See Also
- Five stocks we like better than Allstate
- What Investors Need to Know to Beat the Market
- OpenAI’s Restructuring Sets up What Could Be the Biggest IPO Ever
- What is an Earnings Surprise?
- 2 Rare Earth Stocks the U.S. Government Doesn’t Want to Fail
- Conference Calls and Individual Investors
- CrowdStrike Partners With CoreWeave But Investors Sell the News
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Corporation (NYSE:ALL – Free Report).
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.
